C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/19/2002	WO2002100998A2 Method for generating diversity
12/19/2002	WO2002100900A2 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof
12/19/2002	WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002	WO2002100898A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002	WO2002100895A2 Antimicrobially active peptide
12/19/2002	WO2002100894A2 Dna encoding a mutant peroxisome proliferator-activated receptor gamma coactivator-1 (pgc-1), detection methods and test kits therefor
12/19/2002	WO2002100893A1 A novel polypeptide - granin-9.35 and a polynucleotide encoding the same
12/19/2002	WO2002100891A2 Proteins derived from non-typable haemophilus influenzae (nthi) strain
12/19/2002	WO2002100889A1 Novel epitope of human papilloma virus e7 antigen and cd4-positive t cells activated by the epitope
12/19/2002	WO2002100884A2 Cloned mammalian polyamine oxidase
12/19/2002	WO2002100882A2 Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1
12/19/2002	WO2002100873A1 Processes of purifying oligonucleotides
12/19/2002	WO2002100827A2 Method for increasing the survival of dopamine secreting cells
12/19/2002	WO2002100530A2 Method for controlling fermentation
12/19/2002	WO2002100441A2 Method for treatment of vascular regeneration
12/19/2002	WO2002100435A1 Compositions and methods for enhancing nucleic acid transfer into cells
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002	WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	WO2002100317A2 Targeted particles and methods of using the same
12/19/2002	WO2002100250A2 Wit 3.0, a novel gene to control soft tissue wound healing
12/19/2002	WO2002100199A2 Modifying nicotine and nitrosamine levels in tobacco
12/19/2002	WO2002100172A1 Administration of agents via the pept-2 transporter
12/19/2002	WO2002100168A1 A method for constructing a cloned mammalian embryo
12/19/2002	WO2002100163A2 Cotton event moni5985 and compositions and methods for detection
12/19/2002	WO2002092615A3 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
12/19/2002	WO2002087341A9 Novel self-inactivating (sin) lentiviral vectors
12/19/2002	WO2002085308A3 Antisense and anti-inflammatory based compositions to treat respiratory disorders
12/19/2002	WO2002082904A3 Method of treating or retarding the development of blindness
12/19/2002	WO2002082075A9 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
12/19/2002	WO2002081677A3 Improved gene expression
12/19/2002	WO2002080981A3 Polynucleotide binding complexes comprising sterols and saponins
12/19/2002	WO2002079475A3 Streptococcus pyogenes antigens and corresponding dna fragments
12/19/2002	WO2002074947A3 Method for homologous recombination using the genes bet and exo, but not gam, of the lambda recombination system
12/19/2002	WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
12/19/2002	WO2002072824A3 Human transient receptor potential channel protein.
12/19/2002	WO2002070664A3 Method for rapid detection and identification of bioagents
12/19/2002	WO2002070565A3 High-affinity antagonists of elr-cxc chemokines
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002068603A3 Materials and methods for the induction of premature chromosome condensation
12/19/2002	WO2002068462A3 Internal standard for electrophoretic and chromatographic separation processes
12/19/2002	WO2002066682A3 Rat toxicologically relevant genes and uses thereof
12/19/2002	WO2002066624A3 Novel human protease and polynucleotides encoding the same
12/19/2002	WO2002066611A3 Minimal plasmid vectors that provide for persistent and high level gene expression and methods for using the same
12/19/2002	WO2002066012A3 Amphoteric liposomes and the use thereof
12/19/2002	WO2002064780A9 Dna sequences for human tumour suppressor genes
12/19/2002	WO2002064774A3 Orientation-directed construction of plasmids
12/19/2002	WO2002064755A3 Post-partum mammalian placenta, its use and placental stem cells therefrom
12/19/2002	WO2002059257A3 Method and means for producing barley yellow dwarf virus resistant cereal plants
12/19/2002	WO2002058626A9 Methods and compositions for the identification and treatment of neurodegenerative disorders
12/19/2002	WO2002057455A8 Nucleic acid sequences from drosophila melanogaster that encode proteins essential for larval viability and uses thereof
12/19/2002	WO2002057446A3 Method for treating biomass for producing cell lysate containing plasmid dna
12/19/2002	WO2002055711A3 Method for the production of pantothenic acid by fermentation
12/19/2002	WO2002050293A3 Plants with improved resistance
12/19/2002	WO2002050104A9 Methods and cells for detecting modulators of rgs proteins
12/19/2002	WO2002048353A3 Dna-sequences, which code for an apoptosis signal transduction protein
12/19/2002	WO2002044360A3 Modified arginine deiminase
12/19/2002	WO2002040512A3 Human beta-defensin-3
12/19/2002	WO2002029014A3 Stem cell differentiation-inducing promoter
12/19/2002	WO2002024904A3 Method for producing ribonucleic acid (rna)
12/19/2002	WO2002022825A3 The c. albicans tec1 gene (catec1) and the coded tec1p protein
12/19/2002	WO2002022824A3 Ashbya gossypii genes coding for proteins involved in membrane transport
12/19/2002	WO2002012338A3 Screening method
12/19/2002	WO2002011767A3 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
12/19/2002	WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses
12/19/2002	WO2002004665A3 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors
12/19/2002	WO2001092297A3 Regulation of human lgr4-like g protein-coupled receptor
12/19/2002	WO2001083739A3 Human pellino polypeptides
12/19/2002	WO2001079850A3 Method and apparatus for selective biological material detection
12/19/2002	WO2001079481A8 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
12/19/2002	WO2001077331A9 Human trp-like calcium channel protein-2 (tlcc-2)
12/19/2002	WO2001077169A9 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/19/2002	WO2001075087A3 Subtilisin variants
12/19/2002	WO2001075077A8 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w
12/19/2002	WO2001073060A9 18221, dual specificity phosphatase and uses thereof
12/19/2002	WO2001073050A9 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
12/19/2002	WO2001073026A9 43238, a novel g protein-coupled receptor and uses therefor
12/19/2002	WO2001072994A9 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
12/19/2002	WO2001072977A9 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
12/19/2002	WO2001070948A9 Methods and compositions for elucidating protein expression profiles in cells
12/19/2002	WO2001070032A9 Recombinant parainfluenza virus expression systems and vaccines
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	WO2001066795A8 Method for analysing the length of a nucleic acid molecule
12/19/2002	WO2001004335A3 Human-bovine chimeric respiratory syncytial virus vaccines
12/19/2002	US20020194648 Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants
12/19/2002	US20020194647 Selective control of lignin biosynthesis in transgenic plants
12/19/2002	US20020194646 Methods of creating dwarf phenotypes in plants
12/19/2002	US20020194645 Combinations of genes for producing seed plants exhibiting modulated reproductive development
12/19/2002	US20020194644 Method for increasing stress-resistance to a plant
12/19/2002	US20020194643 Method for producing hemin proteins using plant cells, resulting proteins and products containing same
12/19/2002	US20020194642 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant plants
12/19/2002	US20020194641 PUFA polyketide synthase systems and uses thereof
12/19/2002	US20020194640 Plant promoter derived from luminal binding protein gene and methods for its use
12/19/2002	US20020194639 Bonsai, a phospholipid binding protein, is required for thermal tolerance in arabidopsis
12/19/2002	US20020194638 Vector for genetically modifying non-human animals
12/19/2002	US20020194637 Generation of genetic engineered embryonic stem cells for use in the treatment of parkinson's, huntington's, alzheimer's, diabetes, multiple sclerosis, muscular, bone and liver disorders
12/19/2002	US20020194636 Transgenic mice containing polycystin-related gene disruptions

1 ... 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 ... 4023